You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dose-ranging

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Edmond (SAR443765, Placebo)

Recruiting
  • Asthma
  • Edmond, Oklahoma
    Site number 8400021
Oct 20, 2023

Cannabis, THC Trial (?9-tetrahydrocannabinol)

Not yet recruiting
  • Cannabis
  • THC
  • (no location specified)
Oct 23, 2023

Alzheimer Trial (Buntanetap, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Jan 6, 2023

Obesity Trial in Malaysia (SKF7® Labisia pumila standardized extract)

Completed
  • Obesity
  • SKF7® Labisia pumila standardized extract
  • Ipoh, Malaysia
  • +5 more
May 1, 2023

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Major Depression, Post Traumatic Stress Disorder Trial in Seattle (SM-001)

Not yet recruiting
  • Major Depression
  • Post Traumatic Stress Disorder
  • Seattle, Washington
    AIMS Institute
Jun 13, 2023

Ulcerative Colitis Trial (High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching rectal foam)

Not yet recruiting
  • Ulcerative Colitis
  • High dose budesonide rectal foam
  • +2 more
  • (no location specified)
Jul 28, 2023

Hypogonadotropism Trial in London, (Testosterone, Pump Sprayer)

Not yet recruiting
  • Hypogonadotropism
  • London,, United Kingdom
    Advanced Therapies Centre, The London Clinic
Oct 24, 2022

Lassa Fever Trial in Legon (INO-4500, CELLECTRA™ 2000, Placebo)

Completed
  • Lassa Fever
  • Legon, Accra, Ghana
    Noguchi Memorial Institute for Medical Research, University of G
Nov 18, 2022

Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

Not yet recruiting
  • Pneumococcal Vaccines
  • IVT PCV-25 Formulation A
  • +3 more
  • Vancouver, British Columbia, Canada
  • +3 more
Oct 10, 2023

Psoriasis Trial (SAR441566, Placebo)

Not yet recruiting
  • Psoriasis
  • (no location specified)
Oct 4, 2023

Fructose Intolerance Trial in Iowa City (Placebo, Alanine)

Recruiting
  • Fructose Intolerance
  • Placebo
  • Alanine
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Jul 19, 2022

Post-menopausal Vasomotor Symptoms Trial in West Bend (ACER-801 50 mg BID, ACER-801 100 mg BID, ACER-801 200 mg BID)

Recruiting
  • Post-menopausal Vasomotor Symptoms
  • ACER-801 50 mg BID
  • +3 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Jan 30, 2023

Sexually Transmitted Diseases Trial (Doxycycline)

Not yet recruiting
  • Sexually Transmitted Diseases
  • (no location specified)
May 2, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Tustin, Honolulu (AMG 133, Placebo)

Recruiting
  • Obesity
  • +2 more
  • AMG 133
  • Placebo
  • Tustin, California
  • +1 more
Feb 1, 2023

Lung Cancer Trial in Cambridge, Wythenshawe (OWL-EVO1)

Recruiting
  • Lung Cancer
  • OWL-EVO1
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Aug 19, 2022

Keratoconjunctivitis Sicca, Dry Eye Disease Trial in Cleveland (OTX-101 0.05%, OTX-101 0.09%, Vehicle)

Completed
Has Results
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease
  • OTX-101 0.05%
  • +2 more
  • Cleveland, Ohio
    (unnamed)
Aug 26, 2022

Cognitive Change Trial in Newcastle upon Tyne (Zynamite® 15% 150mg, Zynamite® 15% 300mg, Zynamite® 15% 600mg)

Completed
  • Cognitive Change
  • Zynamite® 15% 150mg
  • +3 more
  • Newcastle upon Tyne, Tyne And Wear, United Kingdom
    Brain performance and nutrition research centre, Northumbria uni
Oct 11, 2022

Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • PIPE-307 Dose A
  • +2 more
  • (no location specified)
Oct 9, 2023

Rheumatoid Arthritis Trial (MBS2320 5 mg, MBS2320 20 mg, MBS2320 40 mg)

Not yet recruiting
  • Rheumatoid Arthritis
  • MBS2320 5 mg
  • +3 more
  • (no location specified)
Jul 12, 2022

Rheumatoid Arthritis Trial (SAR441566, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Oct 4, 2023

Scabies Trial (Moxidectin Oral Product, Placebo)

Not yet recruiting
  • Scabies
  • Moxidectin Oral Product
  • Placebo
  • (no location specified)
May 28, 2023

Migraine, Cannabis, THC Trial in La Jolla (THC ~2.5%, THC ~5%, THC ~10%)

Not yet recruiting
  • Migraine
  • +2 more
  • THC ~2.5%
  • +3 more
  • La Jolla, California
    Center for Pain Medicine, UC San Diego
Jun 17, 2022

Healthy Trial in London (Lysergic Acid Diethylamide (LSD) 50µg, Lysergic Acid Diethylamide (LSD) 75µg, Lysergic Acid

Completed
  • Healthy
  • Lysergic Acid Diethylamide (LSD) 50µg
  • +4 more
  • London, United Kingdom
    PAREXEL, Early Phase Clinical Unit
Jan 5, 2023

Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • nalbuphine ER
  • Placebo
  • (no location specified)
Jul 19, 2023